持続的腎代替療法 (CRRT) の世界市場：2022-2028年

世界の持続的腎代替療法 (CRRT) の市場規模は予測期間中に約5.8%のCAGRで成長すると予測されています。

敗血症の発生率の上昇や、AKIの有病率の上昇などの要因が同市場の成長を推進しています。モダリティ別で見ると、連続静脈血液濾過 (CVVH) の部門が予測期間中にもっとも急速に成長すると予想されています。また、地域別では、アジア太平洋地域が大きなシェアを示すと予測されています。中国やインドなどの経済圏での腎療法の認知度を高めるための政府の取り組みが同地域の成長に起因しています。

当レポートでは、世界の持続的腎代替療法 (CRRT) の市場を調査し、市場概要、市場成長への各種影響因子の分析、市場規模の推移・予測、各種区分・地域/主要国別の内訳、競合環境、主要企業のプロファイルなどをまとめています。

目次

第1章 レポートの概要

第2章 市場概要・洞察

第3章 競合情勢

• 主要企業分析
• 主要戦略分析
• COVID-19が主要企業に与える影響

第4章 市場分析：区分別

• 世界のCRRT市場：製品別
  • 透析液と補液
  • 使い捨て用品
• 世界のCRRT市場：モダリティ別
  • 連続静脈血液濾過 (CVVH)
  • 連続静脈血液透析濾過 (CVVHDF)
  • 連続静脈血液透析 (CVVHD)
  • 低速連続限外濾過 (SCUF)
• 世界のCRRT市場：年齢層別
  • 成人
  • 小児/新生児

第5章 地域分析

• 北米
• 欧州
• アジア太平洋
• その他の地域

第6章 企業プロファイル

• Anjue Medical Equipment Co., Ltd.
• Asahi Kasei Corp.
• B. Braun Melsungen AG
• Baxter International Inc.
• Fresenius Medical Care AG & Co. KGaA
• Infomed SA
• Medica S.p. A.
• Medical Components, Inc.
• Medites Pharma spol. s.r.o.
• Medtronic plc
• NIKKISO CO., LTD.
• Ningbo Tianyi Medical Devices Co., Ltd.
• Nipro Corp. Ltd.
• NxStage Medical, Inc.
• Proxima Medicare
• SWS Hemodialysis Care Co., Ltd.
• Toray Medical Co., Ltd.

LIST OF TABLES

• 1. GLOBAL CRRT MARKET RESEARCH AND ANALYSIS BY PRODUCT, 2021-2028 ($ MILLION)
• 2. GLOBAL DIALYSATES AND REPLACEMENT FLUIDS CRRT MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
• 3. GLOBAL DISPOSABLE CRRT MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
• 4. GLOBAL CRRT MARKET RESEARCH AND ANALYSIS BY MODALITY, 2021-2028 ($ MILLION)
• 5. GLOBAL CONTINUOUS VENOVENOUS HEMOFILTRATION (CVVH) BASED CRRT MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
• 6. GLOBAL CONTINUOUS VENOVENOUS HEMODIAFILTRATION (CVVHDF) BASED CRRT MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
• 7. GLOBAL CONTINUOUS VENOVENOUS HAEMODIALYSIS (CVVHD) BASED CRRT MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
• 8. GLOBAL SLOW CONTINUOUS ULTRAFILTRATION (SCUF) CRRT MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
• 9. GLOBAL CRRT MARKET RESEARCH AND ANALYSIS BY AGE-GROUP, 2021-2028 ($ MILLION)
• 10. GLOBAL CRRT FOR ADULTS MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
• 11. GLOBAL CRRT MARKET RESEARCH AND ANALYSIS BY GEOGRAPHY, 2021-2028 ($ MILLION)
• 12. NORTH AMERICAN CRRT MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
• 13. NORTH AMERICAN CRRT MARKET RESEARCH AND ANALYSIS BY PRODUCT, 2021-2028 ($ MILLION)
• 14. NORTH AMERICAN CRRT MARKET RESEARCH AND ANALYSIS BY MODALITY, 2021-2028 ($ MILLION)
• 15. NORTH AMERICAN CRRT MARKET RESEARCH AND ANALYSIS BY AGE-GROUP, 2021-2028 ($ MILLION)
• 16. EUROPEAN CRRT MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
• 17. EUROPEAN CRRT MARKET RESEARCH AND ANALYSIS BY PRODUCT, 2021-2028 ($ MILLION)
• 18. EUROPEAN CRRT MARKET RESEARCH AND ANALYSIS BY MODALITY, 2021-2028 ($ MILLION)
• 19. EUROPEAN CRRT MARKET RESEARCH AND ANALYSIS BY AGE-GROUP, 2021-2028 ($ MILLION)
• 20. ASIA-PACIFIC CRRT MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
• 21. ASIA-PACIFIC CRRT MARKET RESEARCH AND ANALYSIS BY PRODUCT, 2021-2028 ($ MILLION)
• 22. ASIA-PACIFIC CRRT MARKET RESEARCH AND ANALYSIS BY MODALITY, 2021-2028 ($ MILLION)
• 23. ASIA-PACIFIC CRRT MARKET RESEARCH AND ANALYSIS BY AGE-GROUP, 2021-2028 ($ MILLION)
• 24. REST OF THE WORLD CRRT MARKET RESEARCH AND ANALYSIS BY PRODUCT, 2021-2028 ($ MILLION)
• 25. REST OF THE WORLD CRRT MARKET RESEARCH AND ANALYSIS BY MODALITY, 2021-2028 ($ MILLION)
• 26. REST OF THE WORLD CRRT MARKET RESEARCH AND ANALYSIS BY AGE-GROUP, 2021-2028 ($ MILLION)

LIST OF FIGURES

• 1. IMPACT OF COVID-19 ON GLOBAL CRRT MARKET, 2021-2028 ($ MILLION)
• 2. IMPACT OF COVID-19 ON GLOBAL CRRT MARKET BY SEGMENT, 2021-2028 ($ MILLION)
• 3. RECOVERY OF GLOBAL CRRT MARKET, 2022-2028 (%)
• 4. GLOBAL CRRT MARKET SHARE BY PRODUCT, 2021 VS 2028 (%)
• 5. GLOBAL CRRT MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
• 6. GLOBAL DIALYSATES AND REPLACEMENT FLUIDS CRRT MARKET SHARE BY REGION, 2021 VS 2028 (%)
• 7. GLOBAL DISPOSABLE CRRT MARKET SHARE BY REGION, 2021 VS 2028 (%)
• 8. GLOBAL HEMOFILTER CRRT MARKET SHARE BY REGION, 2021 VS 2028 (%)
• 9. GLOBAL BLOODLINE SETS & TUBES CRRT MARKET SHARE BY REGION, 2021 VS 2028 (%)
• 10. GLOBAL OTHER DISPOSABLES CRRT MARKET SHARE BY REGION, 2021 VS 2028 (%)
• 11. GLOBAL CRRT MARKET SHARE BY MODALITY, 2021 VS 2028 (%)
• 12. GLOBAL CONTINUOUS VENOVENOUS HEMOFILTRATION (CVVH) BASED CRRT MARKET SHARE BY REGION, 2021 VS 2028 (%)
• 13. GLOBAL CONTINUOUS VENOVENOUS HEMODIAFILTRATION (CVVHDF) BASED CRRT MARKET SHARE BY REGION, 2021 VS 2028 (%)
• 14. GLOBAL CONTINUOUS VENOVENOUS HAEMODIALYSIS (CVVHD) BASED CRRT MARKET SHARE BY REGION, 2021 VS 2028 (%)
• 15. GLOBAL SLOW CONTINUOUS ULTRAFILTRATION (SCUF) BASED CRRT MARKET SHARE BY REGION, 2021 VS 2028 (%)
• 16. GLOBAL CRRT MARKET SHARE BY AGE-GROUP, 2021 VS 2028 (%)
• 17. GLOBAL CRRT FOR ADULTS MARKET SHARE BY REGION, 2021 VS 2028 (%)
• 18. GLOBAL CRRT FOR PEDIATRICS /NEONATES MARKET SHARE BY REGION, 2021 VS 2028 (%)
• 19. US CRRT MARKET SIZE, 2021-2028 ($ MILLION)
• 20. CANADA CRRT MARKET SIZE, 2021-2028 ($ MILLION)
• 21. UK CRRT MARKET SIZE, 2021-2028 ($ MILLION)
• 22. FRANCE CRRT MARKET SIZE, 2021-2028 ($ MILLION)
• 23. GERMANY CRRT MARKET SIZE, 2021-2028 ($ MILLION)
• 24. ITALY CRRT MARKET SIZE, 2021-2028 ($ MILLION)
• 25. SPAIN CRRT MARKET SIZE, 2021-2028 ($ MILLION)
• 26. REST OF EUROPE CRRT MARKET SIZE, 2021-2028 ($ MILLION)
• 27. INDIA CRRT MARKET SIZE, 2021-2028 ($ MILLION)
• 28. CHINA CRRT MARKET SIZE, 2021-2028 ($ MILLION)
• 29. JAPAN CRRT MARKET SIZE, 2021-2028 ($ MILLION)
• 30. SOUTH KOREA CRRT MARKET SIZE, 2021-2028 ($ MILLION)
• 31. REST OF ASIA-PACIFIC CRRT MARKET SIZE, 2021-2028 ($ MILLION)
• 32. REST OF THE WORLD CRRT MARKET SIZE, 2021-2028 ($ MILLION)

Title:Global Continuous Renal Replacement Therapy (CRRT) Market Size, Share & Trends Analysis Report by Product (Dialysates and Replacement Fluids and Disposables), by Modality (Continuous Venovenous Hemofiltration (CVVH), Continuous Venovenous Hemodiafiltration (CVVHDF), Continuous Venovenous Hemodialysis (CVVHD), Slow Continuous Ultrafiltration (SCUF)), and by Age-Group (Adults and Pediatrics /Neonates) Forecast Period (2022-2028).

The global CRRT market is projected to grow at a modest CAGR of nearly 5.8% during the forecast period. The key aspect that drives the growth of the market includes the rising prevalence of AKI coupled with the increased incidence of sepsis. For an instance, in an article published by the International Society of Nephrology 2020, countries such as China and India reported an AKI rate of 29% in 2019.

The global CRRT market is segmented based on product, modality, and age-group. Based on product, the market is segmented as dialysates and replacement fluids, and disposables. The disposables segment further includes hemofilter, bloodline sets and tubes, and other disposables. Based on modality, the market is segmented into continuous venovenous hemofiltration (CVVH), continuous venovenous hemodiafiltration (CVVHDF), continuous venovenous hemodialysis (CVVHD), and slow continuous ultrafiltration (SCUF). Among the modality, the Continuous Venovenous Hemofiltration (CVVH) segment is expected to be the fastest-growing segment during the forecast period. Based on age group, the market is segmented as adults, and pediatrics /neonates.

Geographically, the global CRRT market is segmented into North America, Europe, Asia-Pacific, and the Rest of the World. The Asia-Pacific region is projected to hold a significant market share. China, India, Japan, and the Rest of the Asia-Pacific are the major economies primarily contributing to the growth of the continuous renal replacement therapy market in the region. The regional growth of the market is accredited to government initiatives to spread awareness of renal therapy in the economies such as China and India. North America held a major market position in the global continuous renal replacement therapy market.

Further, Medtronic plc, Baxter International Inc., and Fresenius Medical Care AG & CO. KGaA among others are some of the prominent players operating in the market. Strategic initiatives along with competitive pricing may support an increase in the market share of the players during the forecast period. Manufacturers are extensively investing in new technologies. Moreover, new launches & developments, partnerships, collaborations, and mergers and acquisitions are some of the growth strategies adopted by the players to sustain in the highly competitive market. For an instance, in 2019, Fresenius Medical Care AG & CO. KGaA announced the launch of the 4008A dialysis machine in India.

Research Methodology

The market study of the global continuous renal replacement therapy (CRRT) market is incorporated by extensive primary and secondary research conducted by the research team. Secondary research has been conducted to refine the available data to break down the market into various segments, and derive the total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior, and macroeconomic factors. Numbers extracted from secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings the authenticity of our reports.

Secondary Sources Include:

• Financial reports of companies involved in the market

• Whitepapers, research papers, and news blogs

• Company websites and their product catalog

The report is intended for continuous renal replacement therapy (CRRT) companies, manufacturing companies, retail companies, healthcare companies, government organizations, transportation, and logistics companies, software companies, research institutes and universities, other related companies, and government organizations for overall market analysis and competitive analysis. The report provides an in-depth analysis of the market size and growth opportunities. The report will serve as a source for a 360-degree analysis of the market thoroughly delivering insights into the market for better business decisions.

Market Segmentation:

Global Continuous Renal Replacement Therapy (CRRT) Market Research and Analysis by Product.

Global Continuous Renal Replacement Therapy (CRRT) Market Research and Analysis by Modality.

Global Continuous Renal Replacement Therapy (CRRT) Market Research and Analysis by Age-Group.

The Report Covers:

• Comprehensive research methodology of the global continuous renal replacement therapy (CRRT) market.
• This report also includes a detailed and extensive market overview with key analyst insights.
• An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
• Analysis of regional regulations and other government policies impacting the global continuous renal replacement therapy (CRRT) market.
• Insights about market determinants that are stimulating the global continuous renal replacement therapy (CRRT) market.
• Detailed and extensive market segments with regional distribution of forecast revenues.
• Extensive profiles and recent developments of the market player.

Table of Contents

1. Report Summary

• Current Industry Analysis and Growth Potential Outlook
• Impact of COVID-19 on the Global CRRT Industry
• Recovery Scenario of Global CRRT Industry
• 1.1. Research Methods and Tools
• 1.2. Market Breakdown
  • 1.2.1. By Segments
  • 1.2.2. By Geography

2. Market Overview and Insights

• 2.1. Scope of the Report
• 2.2. Analyst Insight & Current Market Trends
  • 2.2.1. Key Findings
  • 2.2.2. Conclusion
• 2.3. Porter's Analysis

3. Competitive Landscape

• 3.1. Key Company Analysis
  • 3.1.1. Baxter International Inc.
    • 3.1.1.1. Overview
    • 3.1.1.2. Financial Analysis
    • 3.1.1.3. SWOT Analysis
    • 3.1.1.4. Recent Developments
  • 3.1.2. Fresenius Medical Care AG & CO. KGaA
    • 3.1.2.1. Overview
    • 3.1.2.2. Financial Analysis
    • 3.1.2.3. SWOT Analysis
    • 3.1.2.4. Recent Developments
  • 3.1.3. Medtronic PLC
    • 3.1.3.1. Overview
    • 3.1.3.2. Financial Analysis
    • 3.1.3.3. SWOT Analysis
    • 3.1.3.4. Recent Developments
• 3.2. Key Strategy Analysis
• 3.3. Impact of COVID-19 on Key Players

4. Market Segmentation

• 4.1. Global CRRT Market by Product
  • 4.1.1. Dialysates and Replacement Fluids
  • 4.1.2. Disposables
    • 4.1.2.1. Hemofilters
    • 4.1.2.2. Bloodline Sets & Tubes
    • 4.1.2.3. Other Disposables
• 4.2. Global CRRT Market by Modality
  • 4.2.1. Continuous Venovenous Hemofiltration (CVVH)
  • 4.2.2. Continuous Venovenous Hemodiafiltration (CVVHDF)
  • 4.2.3. Continuous Venovenous Haemodialysis (CVVHD)
  • 4.2.4. Slow Continuous Ultrafiltration (SCUF)
• 4.3. Global CRRT Market by Age-Group
  • 4.3.1. Adults
  • 4.3.2. Pediatrics /Neonates

5. Regional Analysis

• 5.1. North America
  • 5.1.1. US
  • 5.1.2. Canada
• 5.2. Europe
  • 5.2.1. UK
  • 5.2.2. Germany
  • 5.2.3. Italy
  • 5.2.4. Spain
  • 5.2.5. France
  • 5.2.6. Rest of Europe
• 5.3. Asia-Pacific
  • 5.3.1. China
  • 5.3.2. India
  • 5.3.3. Japan
  • 5.3.4. South Korea
  • 5.3.5. Rest of Asia-Pacific
• 5.4. Rest of the World

6. Company Profiles

• 6.1. Anjue Medical Equipment Co., Ltd.
• 6.2. Asahi Kasei Corp.
• 6.3. B. Braun Melsungen AG
• 6.4. Baxter International Inc.
• 6.5. Fresenius Medical Care AG & Co. KGaA
• 6.6. Infomed SA
• 6.7. Medica S.p. A.
• 6.8. Medical Components, Inc.
• 6.9. Medites Pharma spol. s.r.o.
• 6.10. Medtronic plc
• 6.11. NIKKISO CO., LTD.
• 6.12. Ningbo Tianyi Medical Devices Co., Ltd.
• 6.13. Nipro Corp. Ltd.
• 6.14. NxStage Medical, Inc.
• 6.15. Proxima Medicare
• 6.16. SWS Hemodialysis Care Co., Ltd.
• 6.17. Toray Medical Co., Ltd.